Halma PLC (HLMA)

2,298.0
+23.0(+1.01%)
  • Volume:
    345,892
  • Bid/Ask:
    0.0/0.0
  • Day's Range:
    2,267.0 - 2,319.0

HLMA Overview

Prev. Close
2,275
Day's Range
2,267-2,319
Revenue
1.53B
Open
2,276
52 wk Range
1,855.3-3,270
EPS
0.645
Volume
345,892
Market Cap
8.7B
Dividend (Yield)
18.88
(0.82%)
Average Volume (3m)
777,673
P/E Ratio
35.13
Beta
0.544
1-Year Change
-22.36%
Shares Outstanding
378,470,252
Next Earnings Date
17 Nov 2022
What is your sentiment on Halma?
or
Market is currently closed. Voting is open during market hours.

Halma PLC News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Halma PLC Analysis

Halma PLC Company Profile

Halma PLC Company Profile

Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellNeutralBuyStrong BuyBuy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Sell
SummaryStrong SellNeutralStrong BuyStrong BuyNeutral
  • What is wrong with HLMA today why nearly 4% drop for no reason.
    0
    • and why do you think shares should go up in stright lines? they wouldn't
      0
  • https://www.gov.uk/government/news/government-invests-in-uk-developed-antibody-tests-from-uk-rapid-test-consortium
    0
    • Is this going to dive ( more than the dividend ) just prior the 12th in 2 days time I wonder?
      0